Accreditation

Conference
Tumor Board
Target Audience

This activity is intended for oncologists, pathologists, obstetricians & gynecologists, radiation oncologists, radiologists, surgeons (including surgical oncologists), primary care physicians (PCPs), internal medicine specialists, nurses/nurse practitioners (NPs), physician assistants (PAs), and pharmacists involved in the care of patients with or at risk of breast cancer.

Learning Objectives
At the conclusion of the conference, participants will be better able to:
  • Discuss the clinical trial data for therapies for breast cancer
  • Assess tailoring treatment for patients with breast cancer
  • Relate treatment-related adverse events that occur in patients with breast cancer
  • Apply confidence in their ability to communicate effectively and work as part of the interprofessional team to optimize patient care
Joint Accreditation Statement
Jointly Accredited Provider Logo

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 11.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 11.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates.
Continuing Pharmacy Education
PIM designates this continuing education activity for 11.0 contact hours (1.10 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistants Education
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 11.0 Category 1 credits for completing this activity.
Interprofessional Continuing Education
Jointly Accredited Provider Logo
This activity was planned by and for the healthcare team, and learners will receive 11.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
*Credit amount subject to change
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies.  All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.
Target Audience

This activity is intended for oncologists, pathologists, obstetricians & gynecologists, radiation oncologists, radiologists, surgeons (including surgical oncologists), primary care physicians (PCPs), internal medicine specialists, nurses/nurse practitioners (NPs), physician assistants (PAs), and pharmacists involved in the care of patients with or at risk of breast cancer.

Learning Objectives
At the conclusion of this session, participants will be better able to:
  • Interpret imaging, pathology, and biomarker results from case studies to accurately stage breast cancer and assess risk
  • Develop evidence-based, multimodal treatment strategies following current clinical guidelines and trial data
  • Plan integrated care across surgical, medical, radiation, pathology, and radiology specialties to optimize treatment sequencing
Joint Accreditation Statement
Jointly Accredited Provider Logo

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates.
Continuing Pharmacy Education
PIM designates this continuing education activity for 1.0 contact hours (0.10 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistants Education
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.0 Category 1 credits for completing this activity.
Interprofessional Continuing Education
Jointly Accredited Provider Logo
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
*Credit amount subject to change
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies.  All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.